Skip to main content

State disclosures

The following is information that may affect marketing, sales, and other activities at Axsome Therapeutics Inc. In accordance with state laws, Axsome is disclosing this information in the form required.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

California

AUVELITY® (dextromethorphan-bupropion) – Alzheimer’s disease agitation (ADA)

Colorado

AUVELITY® (dextromethorphan-bupropion) – Alzheimer’s disease agitation (ADA)

Vermont long form

AUVELITY® (dextromethorphan-bupropion) – Alzheimer’s disease agitation (ADA)

Vermont short form

AUVELITY® (dextromethorphan-bupropion) – Alzheimer’s disease agitation (ADA)

California

AUVELITY® (dextromethorphan-bupropion) – Major depressive disorder (MDD)

Colorado

AUVELITY® (dextromethorphan-bupropion) – Major depressive disorder (MDD)

Vermont long form

AUVELITY® (dextromethorphan-bupropion) – Major depressive disorder (MDD)

Vermont short form

AUVELITY® (dextromethorphan-bupropion) – Major depressive disorder (MDD)

California

SUNOSI® (solriamfetol) – Excessive daytime sleepiness (EDS)

Colorado

SUNOSI® (solriamfetol) – Excessive daytime sleepiness (EDS)

Vermont long form

SUNOSI® (solriamfetol) – Excessive daytime sleepiness (EDS)

Vermont short form

SUNOSI® (solriamfetol) – Excessive daytime sleepiness (EDS)

California

SYMBRAVO® (meloxicam and rizatriptan) – Migraine

Colorado

SYMBRAVO® (meloxicam and rizatriptan) – Migraine

Vermont long form

SYMBRAVO® (meloxicam and rizatriptan) – Migraine

Vermont short form

SYMBRAVO® (meloxicam and rizatriptan) – Migraine